last six days, a near double of sharepriceand not one nr to cause that from Canopy.
Coat-tailing on the Democrat's flirting with rescheduling probably from some pro Democrat realization that Biden is going to need some voters to cast their ballots for him and the pot crowd will do that for him if he can garner credit for US legalization or some similar bid that gives the US effort for potpreneurs some traction that hopefully could trigger the great American Greenrush that is there for the waiting for the lawmakers to get their bills/balls right enough to pass.
There won't be any significant resistance from voters who are tired of them wasting time on what the electorate already wants and the big risk imho is them squandering what can be a huge moneymaking event for beat down potpreneurs.
Getting pot legalized at the Federal level in the US has shown what a mockery that US politics can be, driven more by job security from churning these pot bills over and over again without ever coming up with where the will of the voters wants it to be.
Not sure what is driving Canopy but I was right in my thinking that the recent lows would be a good buy-in point to make some money.
And I hope I am wrong about Team Klein bankrupting us for the benefit of the lender to scoop up a leaned out company that should make some huge money as the new US venture they propose as Canopy USA.
Canopy has been subjected to the same gameplan as Acreage to deplete the backbone to bankruptcy levels while getting it ready for a change to support and build rather than continual misses on black ink and deteriorating shareprice and on the verge of bankruptcy.
Today, investors that dared to buy in after the castration consolidation at the hammered down shareprice can capitalize at a near double, if they choose.
The US is closer to something positive for the US pot industry because not doing something could be very costly for the Democrats.
glta and dyodd
ps. My Dad used to tell me that there is nothing wrong with making a profit for those shareholders that dared to buy in to a dying patient.